Tel Aviv [Israel], April 24 (ANI/ TPS): India's Sun Pharma and Israel's Moebius Medical published new data on MM-II, a non-opioid treatment for knee osteoarthritis. The studies, featured in the peer-reviewed Osteoarthritis and Cartilage journal, show that a single injection of MM-II can provide long-lasting pain relief and protect cartilage.
The drug, developed in Israel and supported by Sun Pharma, recently received Fast Track Designation from the US FDA. New findings will be presented at the OARSI 2025 World Congress. (ANI/ TPS)
You may also like
US asks for home addresses, biometrics of H-1B applicants first time ever: 'Highly unusual'
BSF and Punjab Police recover pistol, heroin and drones in Joint Border Operations
Odisha Police busts racket involved in Navy recruitment scam, three held
Pahalgam terror victim's wife recounts horror of attack, says "We hid behind the washroom..."
Jamie Carragher shares new Ollie Watkins to Arsenal transfer theory - 'They didn't'
